Outsourced partners can help innovators make better decisions earlier in development, before uncertainty becomes late-stage risk.
Katie Edgar
Advertisement
Katie Edgar is chief business officer at KBI Biopharma.
Articles by Katie Edgar
Advertisement
Latest Updated Articles
Reshaping Outsourced Development and ManufacturingFebruary 27th 2026
Advertisement
Advertisement
Trending on BioPharm International
1
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
2
Regeneron's Libtayo Earns CHMP Nod for Expanded EU Dosing
3
Biomarker Testing Gaps Can Stall Targeted Oncology Therapy, BMS’s Dr Pennell Says
4
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
5